Glenmark Pharmaceuticals Ltd. Sees -4.19% Decline in Stock Price, Rated ‘Hold’ by MarketsMOJO
On November 7th, 2024, Glenmark Pharmaceuticals Ltd. experienced a -4.19% decline in stock price, leading to a ‘Hold’ rating from MarketsMojo. The stock has underperformed the sector by -3.74% and saw a trend reversal after three days of gains. However, it remains higher than its 100-day and 200-day moving averages, but lower than its 5-day, 20-day, and 50-day moving averages. Despite this, the company remains a strong player in the pharmaceutical industry with its largecap size.
